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Computational systems biologyseems to be caught inwhat we
call the ‘self-assessment trap’, in which researchers wishing
to publish their analytical methods are required by referees or
by editorial policy (e.g., Bioinformatics, BMC Bioinformatics,
Nucleic Acids Research) to compare the performance of their
own algorithms against other methodologies, thus being
forced to be judge, jury and executioner. The result is that
the authors’ method tends to be the best in an unreasonable
majority of cases (Table I). In many instances, this bias is the
result of selective reporting of performance in the niche in
which the method is superior. Evidence of that is that most
papers reporting best performance choose only one or two
metrics of performance, but when the number of performance
metrics is larger than two, most methods fail to be the best in
all categories assessed (Table I). Choosing many metrics can
dramatically change the determination of best performance
(Supplementary Table S1). Selective reporting can be inad-
vertent, but in some cases biases are more disingenuous,
involving hiding information or quietly cutting corners in the
performance evaluation (similar problems have been dis-
cussed in assessments of the performance of supercomputers,
e.g., Bailey (1991)).
Evenassumingthatthereisnoselectivereporting,wewould
like to argue that papers reporting good-yet-not-the-best
methods (of which we found none in our literature survey of
self-assessed papers listed in the Supplementary information)
can still advance science.Forexample, amethod that isnot top
ranked can still have value by unearthing biological results
that are complementary to the results reported by other better
performing methods. Furthermore, the effectiveness of a top-
performing algorithm can be boosted when its results are
aggregated with second and third best performers (Figure 1,
and Supplementary Figures S1 and S2; Marbach et al,2 0 1 0 ;
Prill et al, 2010). The discussion above suggests that self-
evaluation issuspectandthat insistence onpublication ofonly
best performing methods can suppress the reporting of good-
yet-not-best performing methods that also have scientiﬁc value.
In biosciences, as well as in other natural sciences, we
are often faced with situations that have been referred to
as uncomfortable science, a term attributed to statistician
John Tukey, in which the little available data are used both
in the inference model and the conﬁrmatory data analysis.
The resulting overoptimistic ‘conﬁrmatory’ results are often
referred to as ‘systematic bias’. Similarly, ‘information leak’
from data to methods can occur from improper and repeated
cross-validation. In the general case, information leak results
from developing or training an algorithm based on the entire
available data set so that the test set is not independent.
In some cases, the leak can occur subtly and inadvertently
such as when a very similar sample is present both in training
and test set. A better-known effect is ‘overﬁtting’, in which
a model is developed with superior accuracy on its training
data at the cost of reduced generalization of the model to new
data sets. A notable example of this effect can be found in the
Table I Break out of 57 surveyed papers in which the authors assess their
own methods
Number
of
performance
metrics
Total
number
of studies
surveyed
Authors’ method
is the best in
all metrics and
all data sets
Authors’ method
is the best in
most metrics and
most data sets
12 5 1 96
21 5 1 32
37 4 3
44 1 3
54 1 3
62 1 1
Notethatwedid not ﬁnd anyself-assessment paper wherethepresentedmethod
was not top ranked in at least one metric or data set. The survey was conducted
over a large pool of scientiﬁc peer-reviewed papers selected as follows. First,
a Google Scholar search using the keywords ‘computational biology method
assessment’ was conducted. When papers with comparisons of methods were
identiﬁed, we further examined (1) papers from the same journal issue and
(2) downstream papers that cite the identiﬁed paper (as determined by Google
Scholar). The 57 papers (see Supplementary information) resulting from the
search span 22 journals. Most papers are in the categories of gene regulatory
networks/reverse engineering (24/69), structureprediction/assessment(14/69)
and DNA–protein interactions/regulatory element identiﬁcation. An additional
nine papers found in the same manner but not shown in the Table reported
independently (not-self) assessed methods, of which only four were top
performers, whereas ﬁve reported methods that ranked high but were not
top performers.
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Figure 1 The performance metrics Area Under the Precision–Recall curve
(AUPR, left panel) and Area Under the ROC curve (AUROC, right panel) for
individual teams participating in a DREAM2 challenge. The challenge consisted
of predicting transcriptional targets of the transcription factor BCL6. Even when
as the performance of the individual teams decreases (black lineand circles), the
integrated prediction of the best performer and runner-up teams (red line and
diamonds) outperformed the best individual team.
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scientists have scoured high-throughput data to ﬁnd collec-
tions of genes or proteins that can be used in diagnosis or
prognosis of cancer. However, the tools used to ﬁnd signatures
in massive data sets can yield spurious associations with
phenotype (Ioannidis, 2005), even when the results appear
to be statistically sound in self-assessment. In most cases,
unfortunately, these signatures do not generalize; taken to
the task of showing the diagnostics or prognostics value
of these signatures, the accuracy of the predictions is much
pooreron impartial assessments on previously unseen patients
than on the original data. This problem with cancer signatures
is of sufﬁcient general interest to be highlighted recently in the
popular media (Kolata, 2011).
In order to alleviate the overestimation of accuracy from the
manybiassourcesdescribedabove,weproposedafew guidelines:
(i) use third-party validation to test a model with previously
unseen data
(ii) use more than one metric to evaluate the methods
(iii) report well-performing methods even if they are not the
best performers on a particular data set
(iv) increase the awareness of editors and reviewers that
superior performance in self-assessment is a biased
demonstration of the method’s value; instead, impartial
assessment should be the preferred evaluation
(v) Establish a scientiﬁc culture that values timely, well-
conducted follow-up studies that conﬁrm or refute
previous results
To a large extent, the remedies suggested above have been
addressed in the context of genome-wide association studies
(Chanock et al, 2007), and are embodied in existing indepen-
dent assessments presented to the scientiﬁc community in
efforts such as CASP (http://predictioncenter.org/), CAPRI
(http://www.ebi.ac.uk/msd-srv/capri/) and DREAM (http://
www.the-dream-project.org). In contrast to the usual practice
of ‘post-diction’ (retrospective prediction) of known results
as a way to test their methods, participants to these third-
party collaborative competitions (alternatively known as
challenges) submit predictions that are evaluated by impartial
scorers against an independent data set that is hidden from
the participants. The level of performance in these evalua-
tions better tests the generalization ability of the methods,
because the predictions are made based on unseen data, thus
minimizing many of the above-discussed biases. We envision
that a repository of blind challenges and data sets could be
created (DREAM, for example, has 20 such data sets and
challenges) with data produced on demand by third parties,
especially funded to create veriﬁcation data and challenges.
This repository could be used to test the validity of many of
the tasks that we deal with in Systems Biology, Bioinformatics
and Computational Biology.
In summary, systematic bias, information leak and over-
ﬁtting can all be considered facets of the same self-assessment
trap. That is, by knowing too much about the desired results,
the researcher gets snared into a trap of consciously or
unconsciously overestimating performance. Moreover, the
researcher is further lured to the trap by the common
assumption that top performance is required for scientiﬁc
value and publication. By exposing the self-assessment trap,
we hope to lessen its effect with the ultimate goal of advancing
predictive biology and improving human healthcare.
Supplementary information
Supplementary information is available at the Molecular
Systems Biology website (www.nature.com/msb).
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